We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Fetal Surgery for Spina Bifida Shows Benefits

By HospiMedica staff writers
Posted on 09 Oct 2003
Surgeons have reported a number of short-term benefits following fetal surgery for spina bifida, such as a reduced need for a shunt, the reversal of hindbrain herniation, and better-than-expected neurologic function in the infants' legs. More...
The outcomes were reported in the September 2003 issue of the American Journal of Obstetrics and Gynecology.

The mean gestational age of the fetuses undergoing surgery was 23 weeks, and their mean gestational age at birth was 34 weeks. Of the 50 fetuses undergoing surgery, three died from complications following premature delivery. The remaining 47 all had reversal of the hindbrain herniation, but only 20 (43%) needed a shunt, compared to 85% of shunting for babies who had surgery after birth. Twenty-four of the infants had better neurologic leg function than predicted.

The surgeries were performed by doctors at the Children's Hospital of Philadelphia (PA, USA; www.chop.edu). They hoped that by performing the surgery 20-25 weeks prior to gestation might prevent the progressive neurologic injury that occurs during the later part of pregnancy. However, they noted that this must be balanced against the risk of preterm delivery and the risks to the mother. The doctors did not operate on fetuses in whom fetal ultrasound detected irreversible neurologic damage nor on fetuses in whom the spina bifida occurred at a spinal level that would not be expected to cause neurologic damage.

The authors caution that long-term studies are needed to further evaluate leg function, bladder and bowel function, and neurodevelopment beyond the infant period.




Related Links:
Children's Hospital

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.